Soak away diabetes risks? study tests hot foot baths for better blood sugar
NCT ID NCT05269589
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether soaking your feet in hot water for 12 weeks can improve blood sugar control and blood vessel function in adults with type 2 diabetes. Researchers will compare hot water foot baths to neutral temperature foot baths in 44 people aged 45-75. The goal is to see if this simple home therapy can reduce heart disease risk.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- hot water foot baths
- What this could lead to
- If it works, this could offer a simple, drug-free way to help manage blood sugar and heart health in type 2 diabetes.
- What could go wrong
- This is a small early study with only 44 people, so results may not apply widely. The benefit may be small or not happen at all.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 44 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2022
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 45-75 years * Diagnosis of type 2 diabetes mellitus ≥1 year * Stable medication ≥12 weeks Exclusion Criteria: * Class 3 obesity * Hypertension not controled by medication * Diagnosis of cardiac, renal and/or pulmonary disease * Diagnosis of severe neuropathy and/or retinopathy * Insulin therapy * Fasting plasma triglycerides \>5.0 mmol/L * Fasting total cholesterol \>7 mmol/l
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre ÉPIC, Montreal Heart Institute
RECRUITINGMontreal, Quebec, H1T1N6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a text message save lives in a heat wave?
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can a vegan diet shield police officers from heart disease?
- Can a health coach in your patient portal help you lose weight?
- Common antibiotic may boost diabetes control